AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

PULSE BIOSCIENCES, INC. Director's Dealing 2017

Feb 13, 2017

32093_dirs_2017-02-13_9ed820cf-312d-4ff5-8e04-513f5eb80f8d.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-02-09

Reporting Person: Zanganeh Maky (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	258935	Direct
Common Stock	20474	Indirect